Autonomic dysfunction predicts early cardiac affection in patients with systemic sclerosis

Clinical Medicine Insights: Arthritis and Musculoskeletal Disorders

Volumn 3, Issue , 2010, Pages 43-54

  Othman, Khaled M ^a   Assaf, Naglaa Youssef ^a   Farouk, Hanan Mohamed ^a   Aly Hassan, Iman M ^a  

^a AIN SHAMS UNIVERSITY   (Egypt)

Author keywords

Autonomic dysfunction; Heart rate variability; Systemic sclerosis

Indexed keywords

CENTROMERE ANTIBODY; SCL 70 ANTIBODY;

ADULT; ARTICLE; AUTONOMIC DYSFUNCTION; CASE CONTROL STUDY; CLINICAL ARTICLE; CLINICAL EXAMINATION; CLINICAL FEATURE; COLOR ULTRASOUND FLOWMETRY; CONTROLLED STUDY; DIASTOLIC DYSFUNCTION; DISEASE DURATION; ELECTROCARDIOGRAM; FEMALE; HEART ARRHYTHMIA; HEART DISEASE; HEART FUNCTION; HEART RATE VARIABILITY; HEART VENTRICLE EXTRASYSTOLE; HOLTER MONITORING; HUMAN; MALE; NON INVASIVE MEASUREMENT; PREDICTION; PREVALENCE; RAYNAUD PHENOMENON; SCORING SYSTEM; SEROLOGY; SKINFOLD THICKNESS; SUDDEN DEATH; SUPRAVENTRICULAR TACHYCARDIA; SYSTEMIC SCLEROSIS; TRANSTHORACIC ECHOCARDIOGRAPHY;

EID: 77955351115     PISSN: None     EISSN: 11795441     Source Type: Journal    
DOI: 10.4137/cmamd.s4940     Document Type: Article

References (46)

1. D'Andrea A, Bellissimo S, Scotto di Uccio F, et al. Associations of right ventricular myocardial function with skin and pulmonary involvement in asymptomatic patients with systemic sclerosis. Ital Heart J. 2004;5:831-9.
2. Geyer M, Muller-Ladner U. The pathogenesis of systemic sclerosis. Clin Rev Allergy Immunol. 2010;20 (Epub ahead of print).
3. Mouthon L, Garcia De La Pena-Lefebvre P, Chanseaud Y, Tamby MC, Boissier MC, Guillevin L. [Pathogenesis of systemic scleroderma: immunological aspects] (in French). Ann Med Interne (Paris). 2002;153:167-78.
4. Poanta L, Dadu R, Tiboc C, Rednic S, Dumitrascu D. Systolic and diastolic function in patients with systemic sclerosis. Eur J Intern Med. 2009;20: 378-82.
5. Ferri C, Emdin M, Giuggioli D, et al. Autonomic dysfunction in systemic sclerosis: time and frequency domain 24 hour heart rate variability analysis. Br J Rheumatol. 1997;36:669-76.
6. Marasini B, Massarotti M, Cossutta R. Scleroderma heart disease. Int J Immunopathol Pharmacol. 2005;18:609-14.
7. Seferovic PM, Ristic AD, Maksimovic R, et al. Cardiac arrhythmias and conduction disturbances in autoimmune rheumatic diseases. Rheumatology (Oxford). 2006;45 Suppl 4:iv39-42.
8. Kahan A, Coghlan G, McLaughlin V. Cardiac complications of systemic sclerosis. Rheumatology (Oxford). 2009;48 Suppl 3:iii45-8.
9. Ferri C, Giuggioli D, Sebastiani M, Colaci M, Emdin M. Heart involvement and systemic sclerosis. Lupus. 2005;14:702-7.
10. Cozzolino D, Naclerio C, Iengo R, D'Angelo S, Cuomo G, Valentini G. Cardiac autonomic dysfunction precedes the development of fibrosis in patients with systemic sclerosis. Rheumatology (Oxford). 2002;41:586-8.
11. Grossman P, Karemaker J, Wieling W. Prediction of tonic parasympathetic cardiac control using respiratory sinus arrhythmia: the need for respiratory control. Psychophysiology. 1991;28:201-16.
12. Kleiger RE, Bigger JT, Bosner MS, et al. Stability over time of variablesmeasuring heart rate variability in normal subjects. Am J Cardiol. 1991;68: 626-30.
13. Cripps TR, Malik M, Farrell TG, Camm AJ. Prognostic value of reduced heart rate variability after myocardial infarction: clinical evaluation of a new analysis method. Br Heart J. 1991;65:14-9.
14. Farrell TG, Paul V, Cripps TR, Malik M, Bennett ED, Ward D, Camm AJ: Baroreflex sensitivity and electrophysiological correlates in patients after acute myocardial infarction. Circulation. 1991;83:945-52.
15. Wozniak J, Dabrowski R, Luczak D, et al. Evaluation of heart rhythm variability and arrhythmia in children with systemic and localized scleroderma. J Rheumatol. 2009;36:191-6.
16. Bienias P, Ciurzynski M, Glinska-Wielochowska M, et al. Heart rate turbulence assessment in systemic sclerosis: the role for the detection of cardiac autonomic nervous system dysfunction. Rheumatology (Oxford). 2010;49:355-60.
17. Masi A, Rodnan G, Medsger T. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association diagnostic and therapeutic criteria committee. Arthritis Rheum. 1980;23:581-90.
18. Clements P, Lachenbruch P, Siebold J, et al. Inter- and intraobserver variability of total skin thickness score (modified Rodnan TSS) in systemic sclerosis. J Rheumatol. 1995;22:1281-5.
19. LeRoy EC, Black C, Fleischmajer R, et al. Scleroderma (systemic sclerosis): Classification, subsets and pathogenesis. J Rheumatol. 1988;15:202-5.
20. Cheitlin MD, Armstrong WF, Aurigemma GP, et al. ACC/AHA/ASE 2003 guideline update for the clinical application of echocardiography: summary article. A report of the American College of Cardiology/American Heart Association task force on practice guidelines (ACC/AHA/ASE) committee to update the 1997 guidelines for the clinical application of echocardiography). J Am Soc Echocardiogr. 2003;16:1091-110.
21. Lindqvist P, Caidahl K, Neuman-Andersen G, et al. Disturbed right ventricular diastolic function in patients with systemic sclerosis: a Doppler tissue imaging study. Chest. 2005;128:755-63.
22. Task Force of the European Society of Cardiology and the North American Society of pacing and Electrophysiology. Heart rate variability: standards of measurement, physiological interpretation and clinical use. Task force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Circulation. 1996;93:1043-65.
23. Lanza GA, Guido V, Galeazzi MM, et al. Prognostic role of heart rate variability in patients with a recent acute myocardial infarction. Am J Cardiol. 1998;82:1323-8.
24. Fei L. Effect of pharmacological intervention on heart rate variability: animal experiments and clinical observation. In: Malik M, Cam AJ, editors. Heart Rate Variability. Armonk, NY: Futura. 1995;275-91.
25. Akselrod S, Gordon D, Ubel FA, Shannon DC, Berger AC, Cohen RJ. Power spectrum analysis of heart rate fluctuation: a quantitative probe of beat-to-beat cardiovascular control. Science. 1981;213:220-2.
26. Pagani M, Lombardi F, Guzzetti S, et al. Power spectral density of heart rate variability as an index of sympatho-vagal interaction in normal and hypertensive subjects. J Hypertens Suppl. 1984;2:S383-5.
27. Malliani A, Pagani M, Lombardi F, Cerutti S. Cardiovascular neural regulation explored in the frequency domain. Circulation. 1991;84:482-92.
28. Knapp RG, Miller MC. Clinical Epidemiology and Biostatistics. National Medical Series. Baltimore: Williams & Wilkins, 1992;ch., 3, pp. 31-45.
29. Meune C, Vignaux O, Kahan A, Allanore Y. Heart involvement in systemic sclerosis: Evolving concept and diagnostic methodologies. Arch Cardiovasc Dis. 2010;103:46-52.
30. Muller-Ladner U, Distler O, Ibba-Manneschi L, Neumann E, Gay S. Mechanisms of vascular damage in systemic sclerosis. Autoimmunity. 2009;42:587-95.
31. Barron HV, Lesh MD. Autonomic nervous system and sudden cardiac death. J Am Coll Cardiol. 1996;27:1053-60.
32. Klein AL, Leung DY, Murray RD, Urban LH, Bailey KR, Tajik AJ. Effects of age and physiologic variables on right ventricular filling dynamics in normal subjects. Am J Cardiol. 1999;84:440-8.
33. Giunta A, Tirri E, Maione S, Cangianiello S, et al. Right ventricular diastolic abnormalities in systemic sclerosis. Relation to left ventricular involvement and pulmonary hypertension. Ann Rheum Dis. 2000;59:94-8.
34. Dimitroulas T, Giannakoulas G, Papadopoulou K, et al. Early detection of cardiac involvement in systemic sclerosis assessed by tissue-Doppler echocardiography: relationship with neurohormonal activation and endothelial dysfunction. J Rheumatol. 2010;1 (Epub ahead of print).
35. Iovino P, Valentini G, Ciacci C, et al. Proximal stomach function in systemic sclerosis: relationship with autonomic nerve function. Dig Dis Sci. 2001;46:723-30.
36. Stacher G, Merio R, Budka C, Schneider C, Smolen J, Tappeiner G. Cardiovascular autonomic function, autoantibodies and esophageal motor activity in patients with systemic sclerosis and mixed connective tissue disease. J Rheumatol. 2000;27:692-97.
37. Bielous-Wilk A, Poreba M, Staniszewska-Marszalek E, et al. Electrocardiographic evaluation in patients with systemic scleroderma and without clinically evident heart disease. Ann Noninvasive Electrocardiol. 2009;14: 251-7.
38. Malik M, Camm AJ. Heart rate variability and clinical cardiology. Br Heart J. 1994;71:3-6.
39. Kawase H, Maeda M, Horai T, Wada H, Kitajima Y, Seishima M. [Autonomic nerve function in patients with systemic scleroderma using heart rate variability analysis] (in Japanese). Rinsho Byori. 2006;54:325-8.
40. Pancera P, Sansone S, Presciuttini B, et al. Autonomic nervous system dysfunction in sclerodermic and primary Raynaud's phenomenon. Clin Sci (Lond). 1999;96:49-57.
41. Morelli S, Piccirillo G, Fimognari F, et al. Twenty-four hour heart period variability in systemic sclerosis. J Rheumatol. 1996;23:643-5.
42. Hermosillo AG, Ortiz R, Dabague J, Casanova JM, Martinez-Lavin M. Autonomic dysfunction in diffuse scleroderma vs. crest: an assessment by computerized heart rate variability. J Rheumatol. 1994;21:1849-54.
43. D'Andrea A, Stisi S, Bellissimo S, et al. Early impairment of myocardial function in systemic sclerosis: non-invasive assessment by Doppler myocardial and strain rate imaging. Eur J Echocardiogr. 2005;6:407-18.
44. Nakajima K, Taki J, Kawano M, et al. Diastolic dysfunction in patients with systemic sclerosis detected by gated myocardial perfusion spect: an early sign of cardiac involvement. J Nucl Med. 2001;42:183-8.
45. Appel ML, Berger RD, Saul JP, Smith JM, Cohen RJ. Beat to beat variability in cardiovascular variables: noise or music? J Am Coll Cardiol. 1989;14:1139-48.
46. Casolo G, Balli E, Taddei T, Amuhasi J, Gori C. Decreased spontaneous heart rate variability in congestive heart failure. Am J Cardiol. 1989;64:1162-7.